Canadian paediatricians' approaches to managing patients with adverse events following immunization: The role of the Special Immunization Clinic network
- PMID: 25332661
- PMCID: PMC4173958
Canadian paediatricians' approaches to managing patients with adverse events following immunization: The role of the Special Immunization Clinic network
Abstract
Background: When moderate or severe adverse events occur after vaccination, physicians and patients may have concerns about future immunizations. Similar concerns arise in patients with underlying conditions whose risk for adverse events may differ from the general population. The Special Immunization Clinic (SIC) network was established in 2013 at 13 sites in Canada to provide expertise in the clinical evaluation and vaccination of these patients.
Objectives: To assess referral patterns for patients with vaccine adverse events or potential vaccine contraindications among paediatricians and to assess the anticipated utilization of an SIC.
Methods: A 12-item questionnaire was distributed to paediatricians and subspecialists participating in the Canadian Paediatric Surveillance Program through monthly e-mail and mail contacts.
Results: The response rate was 24% (586 of 2490). Fifty-three percent of respondents practiced general paediatrics exclusively and 52% reported that they administer vaccines. In the previous 12 months, 26% of respondents had encountered children with challenging adverse events or potential vaccine contraindications in their practice and 29% had received referrals for such patients, including 27% of subspecialists. Overall, 69% of respondents indicated that they would be likely or very likely to refer patients to an SIC, and 34% indicated that they would have referred at least one patient to an SIC in the previous 12 months.
Conclusions: Patients who experience challenging adverse events following immunization or potential vaccine contraindications are encountered by paediatricians and subspecialists in all practice settings. The SIC network will be able to respond to a clinical need and support paediatricians in managing these patients.
Historique: Lorsque des effets secondaires modérés ou graves surviennent après l’immunisation, les médecins et les patients peuvent s’inquiéter des réactions éventuelles aux futurs vaccins. Des inquiétudes similaires sont soulevées au sujet des patients ayant une maladie sous-jacente et dont les risques d’effets secondaires sont différents de ceux de la population générale. Un réseau de cliniques spéciales en immunisation a été créé en 2013 dans 13 centres canadiens afin d’offrir des compétences dans l’évaluation clinique et la vaccination de ces patients.
Objectifs: Chez les pédiatres, évaluer les profils d’aiguillage des patients présentant des effets secondaires suivant l’immunisation ou des contre-indications potentielles à la vaccination ainsi que l’utilisation prévue d’une clinique d’immunisation spéciale.
Méthodologie: Les pédiatres et les surspécialistes participant au Programme canadien de surveillance pédiatrique par des courriels et des envois postaux mensuels ont reçu un sondage de 12 questions.
Résultats: Le taux de réponse s’élevait à 24 % (586 répondants sur une possibilité de 2 490). Cinquante-trois pour cent d’entre eux exerçaient exclusivement en pédiatrie générale, et 52 % ont déclaré administrer des vaccins. Au cours des 12 mois précédents, 26 % des répondants avaient évalué des enfants ayant des effets secondaires problématiques ou une contre-indication potentielle à la vaccination dans leur pratique et 29 %, dont 27 % de surspécialistes, avaient reçu des demandes de consultation au sujet de tels patients. Dans l’ensemble, 69 % des répondants ont indiqué qu’ils seraient susceptibles ou très susceptibles d’orienter des patients vers une CIS, et 34 % qu’ils auraient orienté au moins un patient vers une CIS au cours des 12 mois précédents.
Conclusions: Les pédiatres et les surspécialistes en pédiatrie évaluent des patients ayant des effets secondaires problématiques suivant l’immunisation ou des contre-indications potentielles à la vaccination dans tous les milieux de pratique. Le réseau de cliniques spéciales en immunisation répondra à un besoin clinique et soutiendra les pédiatres dans leur prise en charge de ces patients.
Keywords: Adverse events; Immunization; Referral.
Similar articles
-
Canadian paediatricians' opinions on rotavirus vaccination.Vaccine. 2011 Apr 12;29(17):3177-82. doi: 10.1016/j.vaccine.2011.02.044. Epub 2011 Mar 2. Vaccine. 2011. PMID: 21376118
-
A(H1N1) pandemic influenza and its prevention by vaccination: paediatricians' opinions before and after the beginning of the vaccination campaign.BMC Public Health. 2011 Feb 22;11:128. doi: 10.1186/1471-2458-11-128. BMC Public Health. 2011. PMID: 21342511 Free PMC article.
-
Canadian family physicians' and paediatricians' knowledge, attitudes and practices regarding A(H1N1) pandemic vaccine.BMC Res Notes. 2010 Apr 14;3:102. doi: 10.1186/1756-0500-3-102. BMC Res Notes. 2010. PMID: 20398265 Free PMC article.
-
Adverse events associated with paediatric use of complementary and alternative medicine: Results of a Canadian Paediatric Surveillance Program survey.Paediatr Child Health. 2009 Jul;14(6):385-7. doi: 10.1093/pch/14.6.385. Paediatr Child Health. 2009. PMID: 20592974 Free PMC article.
-
Allergic reactions to Japanese encephalitis vaccine.Immunol Allergy Clin North Am. 2003 Nov;23(4):665-97. doi: 10.1016/s0889-8561(03)00102-4. Immunol Allergy Clin North Am. 2003. PMID: 14753386 Review.
Cited by
-
Canada's eight-component vaccine safety system: A primer for health care workers.Paediatr Child Health. 2017 Jul;22(4):e13-e16. doi: 10.1093/pch/pxx073. Epub 2017 Jun 15. Paediatr Child Health. 2017. PMID: 29507505 Free PMC article.
-
Knowledge, practice and approaches of health professionals to adverse events following immunization and their reporting in Albania.Heliyon. 2017 Jun 20;3(6):e00331. doi: 10.1016/j.heliyon.2017.e00331. eCollection 2017 Jun. Heliyon. 2017. PMID: 28664193 Free PMC article.
-
Authors' reply: Safety of Human Papillomavirus Vaccines.Drug Saf. 2018 May;41(5):541-543. doi: 10.1007/s40264-018-0655-1. Drug Saf. 2018. PMID: 29582391 No abstract available.
References
-
- Callreus T. Perceptions of vaccine safety in a global context. Acta Paediatr. 2010;99:166–71. - PubMed
-
- Barlow WE, Davis RL, Glasser JW, et al. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. New Engl J Med. 2001;345:656–61. - PubMed
-
- Le Saux N, Barrowman NJ, Moore DL, et al. Decrease in hospital admissions for febrile seizures and reports of hypotonic-hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: A report from IMPACT. Pediatrics. 2003;112:e348. - PubMed
-
- Bohlke K, Davis RL, Marcy SM, et al. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics. 2003;112:815–20. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources